Trial Outcomes & Findings for Clinical Evaluation of a Daily Wear Monthly Replacement Silicone Hydrogel Lens (NCT NCT04178720)

NCT ID: NCT04178720

Last Updated: 2021-10-19

Results Overview

Visual acuity (VA) was assessed for each eye individually with study lenses in place at a distance of 6 meters using a letter chart. VA was collected in Snellen and converted to logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity. No formal hypothesis testing was planned.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

119 participants

Primary outcome timeframe

Dispense, Week 1 follow-up, Week 2 follow-up, Month 1 follow-up, Month 2 follow-up, Month 3 follow-up (at least 4 hours after lens insertion at each follow-up assessment visit)

Results posted on

2021-10-19

Participant Flow

Subjects were enrolled at 8 investigative sites located in the US.

Of the 119 enrolled, 1 subject was screen failed. This reporting group includes all enrolled and dispensed subjects/eyes (118/236).

Unit of analysis: eyes

Participant milestones

Participant milestones
Measure
Biofinity
Comfilcon A contact lenses worn in both eyes at least approximately 8 hours per day and approximately 5 days per week during waking hours only, as randomized. Lenses were removed nightly for cleaning and disinfection and replaced monthly over the 3-month wear period.
LID018869
Lehfilcon A contact lenses worn in both eyes at least approximately 8 hours per day and approximately 5 days per week during waking hours only, as randomized. Lenses were removed nightly for cleaning and disinfection and replaced monthly over the 3-month wear period.
Overall Study
STARTED
40 80
78 156
Overall Study
COMPLETED
38 76
77 154
Overall Study
NOT COMPLETED
2 4
1 2

Reasons for withdrawal

Reasons for withdrawal
Measure
Biofinity
Comfilcon A contact lenses worn in both eyes at least approximately 8 hours per day and approximately 5 days per week during waking hours only, as randomized. Lenses were removed nightly for cleaning and disinfection and replaced monthly over the 3-month wear period.
LID018869
Lehfilcon A contact lenses worn in both eyes at least approximately 8 hours per day and approximately 5 days per week during waking hours only, as randomized. Lenses were removed nightly for cleaning and disinfection and replaced monthly over the 3-month wear period.
Overall Study
Withdrawal by Subject
2
0
Overall Study
Relocation
0
1

Baseline Characteristics

Clinical Evaluation of a Daily Wear Monthly Replacement Silicone Hydrogel Lens

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Biofinity
n=40 Participants
Comfilcon A contact lenses worn in both eyes at least approximately 8 hours per day and approximately 5 days per week during waking hours only, as randomized. Lenses were removed nightly for cleaning and disinfection and replaced monthly over the 3-month wear period.
LID018869
n=78 Participants
Lehfilcon A contact lenses worn in both eyes at least approximately 8 hours per day and approximately 5 days per week during waking hours only, as randomized. Lenses were removed nightly for cleaning and disinfection and replaced monthly over the 3-month wear period.
Total
n=118 Participants
Total of all reporting groups
Age, Continuous
32.9 years
STANDARD_DEVIATION 7.3 • n=5 Participants
34.4 years
STANDARD_DEVIATION 7.6 • n=7 Participants
33.9 years
STANDARD_DEVIATION 7.5 • n=5 Participants
Sex: Female, Male
Female
31 Participants
n=5 Participants
57 Participants
n=7 Participants
88 Participants
n=5 Participants
Sex: Female, Male
Male
9 Participants
n=5 Participants
21 Participants
n=7 Participants
30 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
n=5 Participants
4 Participants
n=7 Participants
6 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
38 Participants
n=5 Participants
74 Participants
n=7 Participants
112 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
2 Participants
n=5 Participants
12 Participants
n=7 Participants
14 Participants
n=5 Participants
Race (NIH/OMB)
White
36 Participants
n=5 Participants
65 Participants
n=7 Participants
101 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Region of Enrollment
United States
40 participants
n=5 Participants
78 participants
n=7 Participants
118 participants
n=5 Participants

PRIMARY outcome

Timeframe: Dispense, Week 1 follow-up, Week 2 follow-up, Month 1 follow-up, Month 2 follow-up, Month 3 follow-up (at least 4 hours after lens insertion at each follow-up assessment visit)

Population: This analysis population includes all enrolled and dispensed subjects/eyes that completed the study with data at corresponding in-person visit.

Visual acuity (VA) was assessed for each eye individually with study lenses in place at a distance of 6 meters using a letter chart. VA was collected in Snellen and converted to logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity. No formal hypothesis testing was planned.

Outcome measures

Outcome measures
Measure
Biofinity
n=76 eyes
Comfilcon A contact lenses worn in both eyes at least approximately 8 hours per day and approximately 5 days per week during waking hours onl, as randomized. Lenses were removed nightly for cleaning and disinfection and replaced monthly over the 3-month wear period.
LID018869
n=154 eyes
Lehfilcon A contact lenses worn in both eyes at least approximately 8 hours per day and approximately 5 days per week during waking hours only, as randomized. Lenses were removed nightly for cleaning and disinfection and replaced monthly over the 3-month wear period.
Distance VA (logMAR) With Study Lenses - Completed Eyes
Dispense
-0.07 logMAR
Standard Deviation 0.06
-0.07 logMAR
Standard Deviation 0.06
Distance VA (logMAR) With Study Lenses - Completed Eyes
Week 1 follow-up
-0.08 logMAR
Standard Deviation 0.06
-0.07 logMAR
Standard Deviation 0.06
Distance VA (logMAR) With Study Lenses - Completed Eyes
Week 2 follow-up Snellen
-0.07 logMAR
Standard Deviation 0.06
-0.07 logMAR
Standard Deviation 0.06
Distance VA (logMAR) With Study Lenses - Completed Eyes
Month 1 follow-up
-0.07 logMAR
Standard Deviation 0.06
-0.07 logMAR
Standard Deviation 0.06
Distance VA (logMAR) With Study Lenses - Completed Eyes
Month 2 follow-up
-0.06 logMAR
Standard Deviation 0.06
-0.07 logMAR
Standard Deviation 0.07
Distance VA (logMAR) With Study Lenses - Completed Eyes
Month 3 follow-up
-0.07 logMAR
Standard Deviation 0.06
-0.06 logMAR
Standard Deviation 0.11

PRIMARY outcome

Timeframe: Dispense, Week 1 follow-up, Week 2 follow-up, Month 1 follow-up

Population: This analysis population includes all enrolled and dispensed subjects/eyes that discontinued the study early with data at corresponding in-person visit.

Visual acuity (VA) was assessed for each eye individually with study lenses in place at a distance of 6 meters using a letter chart. VA was collected in Snellen and converted to logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity. No formal hypothesis testing was planned.

Outcome measures

Outcome measures
Measure
Biofinity
n=4 eyes
Comfilcon A contact lenses worn in both eyes at least approximately 8 hours per day and approximately 5 days per week during waking hours onl, as randomized. Lenses were removed nightly for cleaning and disinfection and replaced monthly over the 3-month wear period.
LID018869
n=2 eyes
Lehfilcon A contact lenses worn in both eyes at least approximately 8 hours per day and approximately 5 days per week during waking hours only, as randomized. Lenses were removed nightly for cleaning and disinfection and replaced monthly over the 3-month wear period.
Distance VA (logMAR) With Study Lenses - Discontinued Eyes
Dispense
-0.06 logMAR
Standard Deviation 0.07
0.00 logMAR
Standard Deviation 0.00
Distance VA (logMAR) With Study Lenses - Discontinued Eyes
Week 1 follow-up
-0.12 logMAR
Standard Deviation 0.00
-0.12 logMAR
Standard Deviation 0.00
Distance VA (logMAR) With Study Lenses - Discontinued Eyes
Week 2 follow-up
0.00 logMAR
Standard Deviation 0.00
-0.12 logMAR
Standard Deviation 0.00
Distance VA (logMAR) With Study Lenses - Discontinued Eyes
Month 1 follow-up
-0.12 logMAR
Standard Deviation 0.00

Adverse Events

Pre-treatment

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

LID018869 Ocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

LID018869 Nonocular/Systemic

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Biofinity Ocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Biofinity Nonocular/Systemic

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

CDMA Project Lead, Vision Care

Alcon Research, LLC

Phone: 1-888-451-3937

Results disclosure agreements

  • Principal investigator is a sponsor employee Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
  • Publication restrictions are in place

Restriction type: OTHER